MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE Drug Patent Profile
✉ Email this page to a colleague
When do Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate patents expire, and what generic alternatives are available?
Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate is a drug marketed by Taro and is included in one NDA.
The generic ingredient in MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE is magnesium sulfate; potassium sulfate; sodium sulfate. There are one hundred and forty-six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the magnesium sulfate; potassium sulfate; sodium sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate
A generic version of MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE was approved as magnesium sulfate; potassium sulfate; sodium sulfate by TARO on March 19th, 2024.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE?
- What are the global sales for MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE?
- What is Average Wholesale Price for MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE?
Summary for MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE
![MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE drug patent expirations Drug patent expirations by year for MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE](/p/graph/s/t/MAGNESIUM_SULFATE;_POTASSIUM_SULFATE;_SODIUM_SULFATE-patent-expirations.png)
Recent Clinical Trials for MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Daewoong Pharmaceutical Co. LTD. | Phase 3 |
Jinling Hospital, China | N/A |
Albert Einstein College of Medicine | Early Phase 1 |
See all MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE clinical trials
Pharmacology for MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE
Anatomical Therapeutic Chemical (ATC) Classes for MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE
Paragraph IV (Patent) Challenges for MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
SUPREP BOWEL PREP KIT | Oral Solution | magnesium sulfate; potassium sulfate; sodium sulfate | 17.5 g/3.13 g/1.6 g | 022372 | 1 | 2010-11-08 |
US Patents and Regulatory Information for MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Taro | MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE | magnesium sulfate; potassium sulfate; sodium sulfate | SOLUTION;ORAL | 206431-001 | Mar 19, 2024 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |